-27.57% percent quarterly performance for Viking Therapeutics Inc (VKTX) is not indicative of the underlying story
On Friday, Viking Therapeutics Inc (NASDAQ: VKTX) was -2.61% drop from the session before settling in for the closing price of $25.66. A 52-week range